ImmunityBio annual return on equity
2014
2015
2016
2017
2018
2019
2020
ImmunityBio Return on Equity (ROE) Growth & History (IBRX)
ImmunityBio's return on equity was −50,941.68% for fiscal 2020.
View full ImmunityBio company overviewImmunityBio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −50,941.68% | −50823.35 pp |
| 2019 | 2019-12-31 | −118.32% | −65.58 pp |
| 2018 | 2018-12-31 | −52.75% | −15.10 pp |
| 2017 | 2017-12-31 | −37.65% | −0.44 pp |
| 2016 | 2016-12-31 | −37.21% | +77.34 pp |
| 2015 | 2015-12-31 | −114.55% | −91.57 pp |
| 2014 | 2014-12-31 | −22.98% | — |
ImmunityBio quarterly return on equity
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-12-31 | −223.03% | −210.84 pp |
| Q3 2020 | 2020-09-30 | −41.22% | −30.37 pp |
| Q2 2020 | 2020-06-30 | −37.79% | −27.33 pp |
| Q1 2020 | 2020-03-31 | −33.18% | −21.78 pp |
| Q4 2019 | 2019-12-31 | −12.19% | −0.93 pp |
| Q3 2019 | 2019-09-30 | −10.85% | +2.90 pp |
| Q2 2019 | 2019-06-30 | −10.46% | +4.06 pp |
| Q1 2019 | 2019-03-31 | −11.40% | +1.73 pp |
| Q4 2018 | 2018-12-31 | −11.26% | −0.53 pp |
| Q3 2018 | 2018-09-30 | −13.75% | −3.98 pp |
| Q2 2018 | 2018-06-30 | −14.52% | −5.69 pp |
| Q1 2018 | 2018-03-31 | −13.13% | −4.55 pp |
| Q4 2017 | 2017-12-31 | −10.73% | −2.71 pp |
| Q3 2017 | 2017-09-30 | −9.77% | +0.22 pp |
| Q2 2017 | 2017-06-30 | −8.83% | +1.29 pp |
| Q1 2017 | 2017-03-31 | −8.57% | +0.18 pp |
| Q4 2016 | 2016-12-31 | −8.02% | −0.56 pp |
| Q3 2016 | 2016-09-30 | −10.00% | +8.93 pp |
| Q2 2016 | 2016-06-30 | −10.12% | +131.43 pp |
| Q1 2016 | 2016-03-31 | −8.76% | — |
| Q4 2015 | 2015-12-31 | −7.46% | — |
| Q3 2015 | 2015-09-30 | −18.92% | — |
| Q2 2015 | 2015-06-30 | −141.55% | — |
ImmunityBio return on equity trends
Over the last five fiscal years, ImmunityBio's return on equity decreased from −114.55% to −50,941.68%, a change of −50827.13 percentage points. The latest reported quarter, Q4 2020, shows −223.03%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ImmunityBio source filings ↗